A detailed history of J. L. Bainbridge & Co., Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, J. L. Bainbridge & Co., Inc. holds 1,853 shares of ABBV stock, worth $338,969. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,853
Previous 1,848 0.27%
Holding current value
$338,969
Previous $316,000 15.51%
% of portfolio
0.04%
Previous 0.03%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $819 - $996
5 Added 0.27%
1,853 $365,000
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $1,702 - $1,988
11 Added 0.6%
1,848 $316,000
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $1,278 - $1,456
-8 Reduced 0.43%
1,837 $334,000
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $253,872 - $285,919
1,845 New
1,845 $285,000
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $47,865 - $55,124
-331 Reduced 20.55%
1,280 $203,000
Q3 2022

Nov 02, 2022

BUY
$134.21 - $153.93 $7,247 - $8,312
54 Added 3.47%
1,611 $216,000
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $28,375 - $35,206
-215 Reduced 12.13%
1,557 $252,000
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $190,365 - $240,867
1,772 New
1,772 $240,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $323B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track J. L. Bainbridge & Co., Inc. Portfolio

Follow J. L. Bainbridge & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. L. Bainbridge & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on J. L. Bainbridge & Co., Inc. with notifications on news.